The University of Texas at Austin, Austin, TX, USA.
Eur J Appl Physiol. 2011 Apr;111(4):641-6. doi: 10.1007/s00421-010-1678-1. Epub 2010 Oct 16.
For approximately 50 years, hepatic clearance of indocyanine green (ICG) has been used to assess liver function. Steady-state infusion of ICG with simultaneous measurement of arterial and hepatic venous ICG concentrations provides unambiguous measures of the extraction ratio for ICG and the hepatic blood flow rate, but also requires cannulation of a hepatic vein. Transient clearance following injection of a single bolus of ICG, which typically involves only measurement of arterial ICG concentration, is a more commonly used procedure. Since drawing blood from a hepatic vein is often impossible, and, in any event can be difficult, there has been considerable interest in the claim by Grainger et al. (Clin Sci 64:207-212, 1983) that a single-bolus, two-compartment model "enabled the hepatic extraction ratio (ER(ss)) of dye to be determined solely from the plasma disappearance curve". The principal purpose of this paper is to show that the claim by Grainger et al. is not valid because it ignores the fact that a finite fraction of ICG entering the liver passes directly into hepatic veins without being sequestered in the liver. A valid relationship between ER(ss) and parameters determined from single-bolus clearance data is derived in this paper. For individuals with normally functioning livers, the single-bolus method of Grainger et al. yields an extraction ratio approximately 20% too large, but in cirrhotic patients with extensive intrahepatic shunting, the extraction ratio evaluated using the single-bolus method of Grainger et al. may be too large by a factor of two.
近 50 年来,一直使用吲哚菁绿(ICG)的肝清除率来评估肝功能。通过恒速输注 ICG 并同时测量动脉和肝静脉 ICG 浓度,可以明确测量 ICG 的提取比和肝血流量,但这也需要肝静脉插管。单次注射 ICG 后进行瞬态清除,通常仅涉及动脉 ICG 浓度的测量,是一种更常用的方法。由于从肝静脉采血通常是不可能的,而且在任何情况下都可能很困难,因此,Grainger 等人的说法引起了相当大的兴趣,他们声称单剂量、两室模型“可以仅从血浆清除曲线确定染料的肝提取率(ER(ss))”。本文的主要目的是表明 Grainger 等人的说法是无效的,因为它忽略了这样一个事实,即进入肝脏的 ICG 的有限部分会直接进入肝静脉,而不会被滞留在肝脏中。本文推导出了从单剂量清除数据确定的参数与 ER(ss)之间的有效关系。对于功能正常的肝脏个体,Grainger 等人的单剂量方法得出的提取比大约大 20%,但对于具有广泛肝内分流的肝硬化患者,使用 Grainger 等人的单剂量方法评估的提取比可能大两倍。